The director of the company creating the £100 million Haverhill Research Park recently handed out an accolade that the park sponsored.
Nic Rumsey of Carisbrooke Investments presented Horizon Discovery with the BioMedTech Company of the Year Award at the 24th annual Business Weekly Gala Dinner held at Queen’s College Cambridge last Tuesday (March 18). The gong is given to the biomedtech company that has made the most commercial progress in the last 12 months.
The final candidates were Axol Bioscience, Cambridge Epigentix, Endomagnetics, Horizon Discover, Iceni Diagnostics, LinkChina Pharma Solutions, MedImmune, Owlstone and XO1.
Mr Rumsey said: “I am delighted for Horizon Discovery.
“It has become a significant success for the Cambridge life science cluster.
“A leader in genome editing and a pioneer of personalised medicine, Horizon has posted phenomenal growth in 2013.
“Haverhill Research Park is happy to have sponsored the award in order to champion the best BioMedTech companies in Cambridge and the wider region.”
The Business Weekly Awards were started in 1990 to recognise champion companies ahead of the curve in a variety of categories and they create a feel good factor for their staff, investors, and customers, while generating new business potential through the publicity received in Business Weekly’s online and print publications.
For all the latest news see Thursday’s (March 27) Echo.